MEDIROM Healthcare Technologies Inc.
MRM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.24 | -1.60 | -0.19 | -0.07 |
| FCF Yield | -229.17% | -18.43% | -24.93% | -19.22% |
| EV / EBITDA | 11.50 | 24.86 | 15.69 | -21.06 |
| Quality | ||||
| ROIC | -0.90% | -47.99% | 2.02% | -32.38% |
| Gross Margin | 27.07% | 22.98% | 27.36% | 26.16% |
| Cash Conversion Ratio | -9.64 | -5.49 | -4.60 | 0.56 |
| Growth | ||||
| Revenue 3-Year CAGR | 6.07% | 8.07% | 27.67% | 11.45% |
| Free Cash Flow Growth | -147.08% | 4.82% | -23.52% | -48.39% |
| Safety | ||||
| Net Debt / EBITDA | 9.36 | 11.43 | 7.03 | -8.77 |
| Interest Coverage | -0.36 | -10.62 | 9.89 | -39.38 |
| Efficiency | ||||
| Inventory Turnover | 39.92 | 37.57 | 44.27 | 213.57 |
| Cash Conversion Cycle | 36.02 | 65.80 | 21.31 | 1.68 |